Mediwound Ltd Ord Sh (MDWD)

$18.28 -0.10 (-0.54%)
Market Cap 202.34M
Revenue (ttm) 20.22M
Net Income (ttm) -30.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -149.46%
Debt to Equity Ratio 0.04
Volume 38,700
Avg Vol 89,384
Day's Range N/A - N/A
Shares Out 11.09M
Stochastic %K 54%
Beta 0.22
Analysts Strong Sell
Price Target $30.67

Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and ot...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 7 797 14100
Fax: 972 7 797 14111
Address:
42 Hayarkon Street, Yavne, Israel
wblb
wblb Nov. 18 at 3:14 PM
$MDWD village with prob another bad call. SP down 6% in last 2 weeks and mdwd moving up.
0 · Reply
novelty
novelty Nov. 18 at 3:06 PM
$MDWD more lower highs for them to short back to range liws
0 · Reply
novelty
novelty Nov. 18 at 4:34 AM
$MDWD bro every pop gets sold back to where it all began. 14$ test soon enuff. Stock has moved nowhere while spx 7000. Now will take part in the spx crash
0 · Reply
JohnPDaly
JohnPDaly Nov. 17 at 9:37 PM
$LCTX $MDWD $BTC.X
0 · Reply
wblb
wblb Nov. 17 at 9:07 PM
$MDWD No surprise. Village idiot wrong again.
1 · Reply
novelty
novelty Nov. 17 at 6:17 PM
$MDWD 😂
0 · Reply
novelty
novelty Nov. 17 at 3:57 PM
$MDWD testing higher and failing is always worse then lower first.
0 · Reply
novelty
novelty Nov. 17 at 3:26 PM
$MDWD when market sells everything sells. This won’t escape that path.
0 · Reply
novelty
novelty Nov. 17 at 3:14 PM
$MDWD just another lower high for them to continue shorting
0 · Reply
novelty
novelty Nov. 17 at 3:12 PM
$MDWD watch them smack this to 17 for close
0 · Reply
Latest News on MDWD
MediWound to Report Third Quarter 2025 Financial Results

Nov 5, 2025, 7:30 AM EST - 13 days ago

MediWound to Report Third Quarter 2025 Financial Results

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

Nov 3, 2025, 8:00 AM EST - 15 days ago

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

Sep 29, 2025, 8:37 AM EDT - 7 weeks ago

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

Sep 25, 2025, 7:30 AM EDT - 7 weeks ago

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

MediWound's NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

Sep 2, 2025, 7:30 AM EDT - 2 months ago

MediWound's NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

MediWound Is A Buy Opportunity On The Dip

Sep 2, 2025, 5:42 AM EDT - 2 months ago

MediWound Is A Buy Opportunity On The Dip

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 20, 2025, 7:30 AM EDT - 3 months ago

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

MediWound Ltd. (MDWD) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 1:31 PM EDT - 3 months ago

MediWound Ltd. (MDWD) Q2 2025 Earnings Call Transcript

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 14, 2025, 7:00 AM EDT - 3 months ago

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

Aug 13, 2025, 8:45 AM EDT - 3 months ago

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

MediWound to Report Second Quarter 2025 Financial Results

Aug 4, 2025, 7:30 AM EDT - 3 months ago

MediWound to Report Second Quarter 2025 Financial Results

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

May 21, 2025, 12:46 PM EDT - 6 months ago

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 21, 2025, 7:00 AM EDT - 6 months ago

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

MediWound Ltd.: Undervalued High-Growth Potential

May 16, 2025, 10:34 AM EDT - 6 months ago

MediWound Ltd.: Undervalued High-Growth Potential

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

May 13, 2025, 7:30 AM EDT - 6 months ago

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

MediWound to Report First Quarter 2025 Financial Results

May 5, 2025, 8:00 AM EDT - 7 months ago

MediWound to Report First Quarter 2025 Financial Results

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

Apr 28, 2025, 8:00 AM EDT - 7 months ago

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 12:10 PM EDT - 8 months ago

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 19, 2025, 7:00 AM EDT - 8 months ago

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 8:00 AM EST - 9 months ago

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

Feb 25, 2025, 8:00 AM EST - 9 months ago

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

Feb 24, 2025, 8:00 AM EST - 9 months ago

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

MediWound to launch Phase III trial for venous leg ulcers

Feb 12, 2025, 8:12 AM EST - 9 months ago

MediWound to launch Phase III trial for venous leg ulcers

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

Feb 12, 2025, 7:00 AM EST - 9 months ago

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript

Nov 26, 2024, 1:46 PM EST - 1 year ago

MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

Nov 26, 2024, 7:00 AM EST - 1 year ago

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

MediWound Is A Healthy Investment

Oct 29, 2024, 10:49 AM EDT - 1 year ago

MediWound Is A Healthy Investment

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

Oct 10, 2024, 7:00 AM EDT - 1 year ago

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 15, 2024, 4:15 PM EDT - 1 year ago

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 3:00 PM EDT - 1 year ago

MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

Aug 14, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

Aug 5, 2024, 7:30 AM EDT - 1 year ago

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

MediWound to Report Second Quarter 2024 Financial Results

Aug 2, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report Second Quarter 2024 Financial Results

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

Jul 29, 2024, 8:00 AM EDT - 1 year ago

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Jul 16, 2024, 7:30 AM EDT - 1 year ago

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Jul 15, 2024, 7:32 AM EDT - 1 year ago

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

MediWound Announces $25 Million Strategic Private Placement Financing

Jul 15, 2024, 7:00 AM EDT - 1 year ago

MediWound Announces $25 Million Strategic Private Placement Financing

MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript

May 29, 2024, 11:35 AM EDT - 1 year ago

MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

May 29, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

MediWound to Report First Quarter 2024 Financial Results

May 22, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report First Quarter 2024 Financial Results

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

Apr 25, 2024, 8:00 AM EDT - 1 year ago

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

MediWound Ltd. (MDWD) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 11:35 AM EDT - 1 year ago

MediWound Ltd. (MDWD) Q4 2023 Earnings Call Transcript

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Mar 21, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

Mar 14, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

Feb 12, 2024, 7:00 AM EST - 1 year ago

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

MediWound to Participate in Two Upcoming Investor Conferences

Feb 5, 2024, 8:00 AM EST - 1 year ago

MediWound to Participate in Two Upcoming Investor Conferences

MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns

Jan 9, 2024, 7:00 AM EST - 2 years ago

MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army

Dec 28, 2023, 7:00 AM EST - 2 years ago

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army

MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads

Dec 21, 2023, 8:00 AM EST - 2 years ago

MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads

MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript

Nov 21, 2023, 1:14 PM EST - 2 years ago

MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript

wblb
wblb Nov. 18 at 3:14 PM
$MDWD village with prob another bad call. SP down 6% in last 2 weeks and mdwd moving up.
0 · Reply
novelty
novelty Nov. 18 at 3:06 PM
$MDWD more lower highs for them to short back to range liws
0 · Reply
novelty
novelty Nov. 18 at 4:34 AM
$MDWD bro every pop gets sold back to where it all began. 14$ test soon enuff. Stock has moved nowhere while spx 7000. Now will take part in the spx crash
0 · Reply
JohnPDaly
JohnPDaly Nov. 17 at 9:37 PM
$LCTX $MDWD $BTC.X
0 · Reply
wblb
wblb Nov. 17 at 9:07 PM
$MDWD No surprise. Village idiot wrong again.
1 · Reply
novelty
novelty Nov. 17 at 6:17 PM
$MDWD 😂
0 · Reply
novelty
novelty Nov. 17 at 3:57 PM
$MDWD testing higher and failing is always worse then lower first.
0 · Reply
novelty
novelty Nov. 17 at 3:26 PM
$MDWD when market sells everything sells. This won’t escape that path.
0 · Reply
novelty
novelty Nov. 17 at 3:14 PM
$MDWD just another lower high for them to continue shorting
0 · Reply
novelty
novelty Nov. 17 at 3:12 PM
$MDWD watch them smack this to 17 for close
0 · Reply
wblb
wblb Nov. 17 at 3:10 PM
$MDWD How many times can you post and be wrong. I guess every village has an idiot.
1 · Reply
novelty
novelty Nov. 17 at 2:18 PM
$MDWD just remember this name can’t even rally while SPX rallied all year. What u think happens now that downside is here?
0 · Reply
novelty
novelty Nov. 17 at 1:09 AM
$MDWD should be able to pick this one up for 10$ once the crash happens here soon
0 · Reply
novelty
novelty Nov. 14 at 8:36 PM
$MDWD actively shorted name
0 · Reply
novelty
novelty Nov. 14 at 6:45 PM
$MDWD 10 red days for every 1 green day. Bahahaha
0 · Reply
novelty
novelty Nov. 14 at 5:57 PM
$MDWD strong downtrend
0 · Reply
JohnPDaly
JohnPDaly Nov. 14 at 5:24 PM
SEC Filing | MediWound $MDWD https://ir.mediwound.com/node/11996/html
0 · Reply
DiligentInvesting
DiligentInvesting Nov. 14 at 3:39 PM
$LCTX $MDWD $BTC.X And everybody complains about the weather, but nobody does anything about it.
0 · Reply
JohnPDaly
JohnPDaly Nov. 14 at 3:09 PM
$LCTX $MDWD $BTC.X All of humanity's problems stem from man's inability to sit quietly in a room alone. Blaise Pascal,
1 · Reply
novelty
novelty Nov. 14 at 2:14 PM
$MDWD should Nuke today with the rest of market
0 · Reply
novelty
novelty Nov. 13 at 8:34 PM
$MDWD should get our 16’s again soon
0 · Reply
novelty
novelty Nov. 13 at 8:20 PM
$MDWD someone really wants cheap shares
0 · Reply